metaraminol has been researched along with Lung Neoplasms in 1 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic gas embolism during endobronchial laser treatment has been previously reported with poor outcomes and significant mortality." | 1.35 | Transient transmural ischaemia during endobronchial laser treatment: possible coronary artery embolism. ( Claydon, R; Hall, A; Haydon, TP, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haydon, TP | 1 |
| Claydon, R | 1 |
| Hall, A | 1 |
1 other study available for metaraminol and Lung Neoplasms
| Article | Year |
|---|---|
Transient transmural ischaemia during endobronchial laser treatment: possible coronary artery embolism.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; Bronchoscopy; Coro | 2008 |